<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2393-6797</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Medicina Interna ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Urug. Med. Int.]]></abbrev-journal-title>
<issn>2393-6797</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Interna del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2393-67972020000300004</article-id>
<article-id pub-id-type="doi">10.26445/05.03.1</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Adhesión insuficiente a la prevención de la enfermedad tromboembólica venosa en Hospitales Uruguayos. Un grave problema en salud.]]></article-title>
<article-title xml:lang="en"><![CDATA[Insufficient adherence to the prevention of venous thromboembolic disease in Uruguayan Hospitals. A serious health problem.]]></article-title>
<article-title xml:lang="pt"><![CDATA[Insuficiente adesão à prevenção da doença tromboembólica venosa em hospitais uruguaios. Um sério problema de saúde.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carrizo]]></surname>
<given-names><![CDATA[Cecilia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cuadro]]></surname>
<given-names><![CDATA[Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[Lilián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mérola]]></surname>
<given-names><![CDATA[Valentina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pizzarossa]]></surname>
<given-names><![CDATA[Ana Carina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lisa]]></surname>
<given-names><![CDATA[Elena De]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caraballo]]></surname>
<given-names><![CDATA[Natacha]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olivieri]]></surname>
<given-names><![CDATA[Mariela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guillermo]]></surname>
<given-names><![CDATA[Cecilia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[Ana María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>5</volume>
<numero>3</numero>
<fpage>4</fpage>
<lpage>13</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2393-67972020000300004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2393-67972020000300004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2393-67972020000300004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La Enfermedad Tromboembólica Venosa (ETV) es una complicación médica grave, frecuente y prevenible en el paciente hospitalizado. Si bien se ha demostrado la eficacia de su prevención (farmacológica y/o mecánica), su adhesión es insuficiente a nivel internacional y nacional.  Objetivos:  Contribuir al conocimiento de la realidad nacional sobre tromboprofilaxis en el paciente hospitalizado en vistas a optimizar su adherencia. Conocer la prevalencia del riesgo de ETV en la población analizada y evaluar la adherencia a la indicación de tromboprofilaxis.  Metodología.  Estudio observacional, descriptivo, transversal y multicéntrico de todos los pacientes médico-quirúrgicos internados en salas de cuidado moderado del Hospital de Clínicas, Hospital Maciel y Sanatorio Americano, durante el 26 y 27 de Abril 2017. Se estudiaron variables sociodemográficas y el porcentaje de pacientes en riesgo de ETV. En los pacientes de riesgo se valoró el porcentaje que reciben tromboprofilaxis farmacológica.  Resultados.  Se incluyeron 427 pacientes. 63% (269) presentaban patología médica y 37% (158) patología quirúrgica. 294 (68,9%) se encontraban en riesgo de ETV, de los cuales 55,8% (164) recibían profilaxis farmacológica. No la recibían por omisión 19,4% (57), por contraindicación 18,4% (54) y por estar anticoagulados 6,4% (19). Ninguno de los pacientes con contraindicación para tromboprofilaxis farmacológica recibía medidas mecánicas. La población de pacientes en riesgo que recibían tromboprofilaxis era estadísticamente mayor en los pacientes médicos (66,7%, 110/165) que en los quirúrgicos (41,9%, 54/129) p &lt; 0,001. De los 130 pacientes que no tenían indicación de tromboprofilaxis farmacológica 9,3% (12) la recibían. Todos estos pacientes presentaban patología médica.  Conclusiones:  En nuestro estudio encontramos un 68,9 % de pacientes en riesgo, lo que confirma que es un problema grave y frecuente. Con respecto a la tromboprofilaxis, si bien objetivamos una franca mejoría con respecto a estudios nacionales previos, creemos que es aún insuficiente y debemos seguir trabajando esta línea.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Venous Thromboembolic Disease (VTE) is a serious, frequent and preventable medical complication in hospitalized patients. Although the efficacy of its prevention (pharmacological and / or mechanical) has been demonstrated, its adherence is insufficient at the international and national level.  Objectives: Contribute to the knowledge of the national reality on thromboprophylaxis in hospitalized patients in order to optimize their adherence. To know the prevalence of the risk of VTE in the analyzed population and evaluate adherence to the indication of thromboprophylaxis.  Methodology:  Observational, descriptive, cross-sectional and multicenter study of all medical-surgical patients admitted to moderate care wards of Hospital de Clínicas, Hospital Maciel and Sanatorio Americano, during April 26 and 27, 2017. Sociodemographic variables and the percentage of patients were studied at risk of VTE. In patients at risk, the percentage who received pharmacological thromboprophylaxis was assessed.  Results:  427 patients were included. 63% (269) presented medical pathology and 37% (158) surgical pathology. 294 (68.9%) were at risk of VTE, of which 55.8% (164) were receiving pharmacological prophylaxis. They did not receive it by omission 19.4% (57), due to contraindication 18.4% (54) and because they were anticoagulated 6.4% (19). None of the patients with a contraindication for pharmacological thromboprophylaxis received mechanical measures. The population of patients at risk who received thromboprophylaxis was statistically higher in medical patients (66.7%, 110/165) than in surgical patients (41.9%, 54/129) p &lt;0.001. Of the 130 patients who did not have an indication for drug thromboprophylaxis, 9.3% (12) received it. All these patients presented medical pathology.  Conclusions:  In our study we found 68.9% of patients at risk, which confirms that it is a serious and frequent problem. With regard to thromboprophylaxis, although we observed a clear improvement compared to previous national studies, we believe that it is still insufficient and we must continue working on this line.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  A Doença Tromboembólica Venosa (TEV) é uma complicação médica grave, frequente e evitável em pacientes hospitalizados. Embora a eficácia da sua prevenção (farmacológica e / ou mecânica) tenha sido demonstrada, a sua adesão é insuficiente a nível internacional e nacional.  Objetivos: Contribuir para o conhecimento da realidade nacional sobre tromboprofilaxia em pacientes hospitalizados de forma a otimizar a sua adesão. Conhecer a prevalência de risco de TEV na população analisada e avaliar a adesão à indicação de tromboprofilaxia.  Metodologia:  Estudo observacional, descritivo, transversal e multicêntrico de todos os pacientes médico-cirúrgicos internados em unidades de cuidados moderados do Hospital de Clínicas, Hospital Maciel e Sanatorio Americano, durante os dias 26 e 27 de abril de 2017. Foram estudadas variáveis sociodemográficas e o percentual de pacientes em risco de TEV. Em pacientes de risco, foi avaliada a porcentagem que recebeu tromboprofilaxia farmacológica.  Resultados:  427 pacientes foram incluídos. 63% (269) apresentavam patologia médica e 37% (158) patologia cirúrgica. 294 (68,9%) estavam em risco de TEV, dos quais 55,8% (164) recebiam profilaxia farmacológica. Não o receberam por omissão 19,4% (57), por contra-indicação 18,4% (54) e por estarem anticoagulados 6,4% (19). Nenhum dos pacientes com contra-indicação para tromboprofilaxia farmacológica recebeu medidas mecânicas. A população de pacientes em risco que recebeu tromboprofilaxia foi estatisticamente maior em pacientes médicos (66,7%, 110/165) do que em pacientes cirúrgicos (41,9%, 54/129) p &lt;0,001. Dos 130 pacientes que não tinham indicação de tromboprofilaxia medicamentosa, 9,3% (12) a receberam. Todos esses pacientes apresentavam patologia médica.  Conclusões:  Em nosso estudo encontramos 68,9% de pacientes em risco, o que confirma que se trata de um problema grave e frequente. No que se refere à tromboprofilaxia, embora tenhamos observado uma clara melhora em relação aos estudos nacionais anteriores, acreditamos que ainda é insuficiente e devemos continuar trabalhando nessa linha.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad Tromboembólica Venosa]]></kwd>
<kwd lng="es"><![CDATA[Prevención]]></kwd>
<kwd lng="es"><![CDATA[Paciente hospitalizado]]></kwd>
<kwd lng="en"><![CDATA[Venous thromboembolism]]></kwd>
<kwd lng="en"><![CDATA[prevention]]></kwd>
<kwd lng="en"><![CDATA[hospitalised patient]]></kwd>
<kwd lng="pt"><![CDATA[Tromboembolismo venoso]]></kwd>
<kwd lng="pt"><![CDATA[prevenção]]></kwd>
<kwd lng="pt"><![CDATA[paciente hospitalizado]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Geerts]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Bergqvist]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pineo]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
<name>
<surname><![CDATA[Heit]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Samama]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Lassen]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2008</year>
<volume>133</volume>
<numero>6^sSUPPL. 6</numero>
<issue>6^sSUPPL. 6</issue>
<supplement>SUPPL. 6</supplement>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lindblad]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sternby]]></surname>
<given-names><![CDATA[NH]]></given-names>
</name>
<name>
<surname><![CDATA[Bergqvist]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of venous thromboembolism verified by necropsy over 30 years]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>1991</year>
<volume>302</volume>
<numero>6778</numero>
<issue>6778</issue>
<page-range>709-11</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandler]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autopsy proven pulmonary embolism in hospital patients are we detecting enough deep vein thrombosis?]]></article-title>
<source><![CDATA[J R Soc Med]]></source>
<year>1989</year>
<volume>82</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>203-5</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alikhan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Wilmott]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen a]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatal pulmonary embolism in hospitalised patients a necropsy review]]></article-title>
<source><![CDATA[J Clin Pathol]]></source>
<year>2004</year>
<volume>57</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1254-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>National Clinical Guideline Centre - Acute and Chronic Conditions</collab>
<source><![CDATA[Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Hospital]]></source>
<year>2010</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Royal College of Physicians]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Centers for Medicare &amp; Medicaid Services. Joint Commission</collab>
<source><![CDATA[Specifications Manual for National Hospital Inpatient Quality Measures (Specifications Manual)]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Washington DC ]]></publisher-loc>
<publisher-name><![CDATA[QualityNet]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maynard]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Preventing hospital-associated venous thromboembolism: a guide for effective quality improvement]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Rockville ]]></publisher-loc>
<publisher-name><![CDATA[AHRQ Publication]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Agnelli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Arcelus]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bergqvist]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Brecht]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Venous thromboembolism (VTE) in Europe The number of VTE events and associated morbidity and mortality]]></article-title>
<source><![CDATA[Thromb Haemost]]></source>
<year>2007</year>
<volume>98</volume>
<page-range>756-64</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kakkar]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Corrigan]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Spindler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of Fatal Pulmonary Embolism by low doses of heparin. An International Multicentre Trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1975</year>
<volume>2</volume>
<numero>7924</numero>
<issue>7924</issue>
<page-range>45-51</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Samama]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Darmon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Desjardins]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Eldor]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Janbon]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1999</year>
<volume>341</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>793-800</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leizorovicz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2004</year>
<volume>110</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>874-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Gallus]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Lassen]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Prins]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Tomkowski]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Turpie]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Egberts]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Lensing]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[ARTEMIS Investigators]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients randomised placebo controlled trial]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2006</year>
<volume>332</volume>
<numero>7537</numero>
<issue>7537</issue>
<page-range>325-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Spyropoulos]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Chopra]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kaatz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bernstein]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Flanders]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2016</year>
<volume>129</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1001</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Eichorn]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alarcon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McCullagh]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[McGinn]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Spyropoulos]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[External validation of the risk assessment model of the international medical prevention registry on venous thromboembolism (IMPROVE) for medical patients in a tertiary health system]]></article-title>
<source><![CDATA[J Am Heart Assoc]]></source>
<year>2014</year>
<volume>3</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Falck-Ytter]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Francis]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Johanson]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Curley]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[OE]]></given-names>
</name>
<name>
<surname><![CDATA[Schulman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2012</year>
<volume>141</volume>
<numero>^s2 SUPPL</numero>
<issue>^s2 SUPPL</issue>
<supplement>2 SUPPL</supplement>
<page-range>e278S-325S</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jha]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Larizgoitia]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Audera-Lopez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Prasopa-Plaizier]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Waters]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bates]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The global burden of unsafe medical care analytic modelling of observational studies]]></article-title>
<source><![CDATA[BMJ Qual Saf]]></source>
<year>2013</year>
<volume>22</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>809-15</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Crowther]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Meade]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rabbat]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Griffith]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Schiff]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deep venous thrombosis in medical-surgical critically ill patients prevalence, incidence, and risk factors]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2005</year>
<volume>33</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1565-71</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weitz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-molecular-weight heparins]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1997</year>
<volume>337</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>688</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Samama]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[OE]]></given-names>
</name>
<name>
<surname><![CDATA[Quinlan]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mismetti]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rosencher]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quantification of risk factors for venous thromboembolism A preliminary study for the development of a risk assessment tool]]></article-title>
<source><![CDATA[Haematologica]]></source>
<year>2003</year>
<volume>88</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1410-21</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hirsh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Heit]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Prins]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lensing]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low molecular weight heparin a critical analysis of clinical trials]]></article-title>
<source><![CDATA[Pharmacol Rev]]></source>
<year>1994</year>
<volume>46</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>89</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Wells]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Holloway]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Weitz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hirsh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin]]></article-title>
<source><![CDATA[Thromb Haemost]]></source>
<year>1994</year>
<volume>71</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>300</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eriksson]]></surname>
<given-names><![CDATA[BI]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[OE]]></given-names>
</name>
<name>
<surname><![CDATA[Rosencher]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kurth]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[van Dijk]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Frostick]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oral dabigatran etexilate vs subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: The RE-MODEL randomized trial]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2007</year>
<volume>5</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2178-85</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turpie]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Lassen]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Bauer]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Gent]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kwong]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4) a randomised trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2009</year>
<volume>373</volume>
<numero>9676</numero>
<issue>9676</issue>
<page-range>1673-80</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bates]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Greer]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Pabinger]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sofaer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hirsh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2008</year>
<volume>133</volume>
<numero>^sSUPPL. 6</numero>
<issue>^sSUPPL. 6</issue>
<supplement>SUPPL. 6</supplement>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liew]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gao]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbs]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asian venous thromboembolism guidelines prevention of venous thromboembolism]]></article-title>
<source><![CDATA[Int Angiol]]></source>
<year>2012</year>
<volume>31</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>501-16</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gould]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Wren]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Karanicolas]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Arcelus]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Heit]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2012</year>
<volume>141</volume>
<numero>^s2 Suppl</numero>
<issue>^s2 Suppl</issue>
<supplement>2 Suppl</supplement>
<page-range>227-77</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Debourdeau]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Farge]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Beckers]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Baglin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bauersachs]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Brenner]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2013</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>71-80</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Tapson]]></surname>
<given-names><![CDATA[VF]]></given-names>
</name>
<name>
<surname><![CDATA[Bergmann]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Goldhaber]]></surname>
<given-names><![CDATA[SZ]]></given-names>
</name>
<name>
<surname><![CDATA[Kakkar]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Deslandes]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study) a multinational cross-sectional study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2008</year>
<volume>37</volume>
<page-range>387-94</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Purriel Orcoyen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Muras Portas]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Canoso]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Korytnicki Kowaldo]]></surname>
<given-names><![CDATA[IL]]></given-names>
</name>
<name>
<surname><![CDATA[Carlota]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Tromboembolismo]]></source>
<year>1967</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Oficina Libro-AEM]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tomalino]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Niski]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Korytnicki]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Canessa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gherzi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tromboembolismo Pulmonar Recidivante]]></article-title>
<source><![CDATA[La Prensa Médica Uruguaya]]></source>
<year>1979</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad tromboembolica venosa]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Arena]]></surname>
<given-names><![CDATA[ed]]></given-names>
</name>
</person-group>
<source><![CDATA[Hemostasis y Trombosis]]></source>
<year>2005</year>
<page-range>255-67</page-range><publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aco en la enfermedad tromboembólica venosa]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Otero A]]></surname>
<given-names><![CDATA[coord]]></given-names>
</name>
</person-group>
<source><![CDATA[Consenso uruguayo sobre anticoagulación oral.]]></source>
<year>2003</year>
<publisher-loc><![CDATA[SMU ]]></publisher-loc>
<publisher-name><![CDATA[Montevideo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Altman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Trombosis: Fisiologia, mecanismos de enfermedad y tratamiento]]></source>
<year>2008</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Edimed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Margolis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Larre Borges]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cavallo]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Profilaxis de la trombosis venosa profunda en paicentes medicos]]></article-title>
<source><![CDATA[Arch Med Interna]]></source>
<year>1993</year>
<volume>XV</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>103-1015</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zeballos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bazzino]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Cairoli]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Valiño]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Profilaxis de la enfermedad tromboembólica venosa:indicación y realización en pacientes internados en el Hospital de Clínicas]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Belloso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermedad Tromboembólica Venosa]]></source>
<year>2004</year>
<edition>2</edition>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Arena]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Estévez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trabajo multicéntrico sobre profilaxis de la Enfermedad Tromboembólica Venosa ( ETEV )]]></article-title>
<source><![CDATA[Arch Med Interna]]></source>
<year>2007</year>
<volume>XXIX</volume>
<page-range>46-51</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tafuri]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Guillermo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<collab>Olivieri M et al</collab>
<source><![CDATA[Tromboprofilaxis?: utilidad de una alerta escrita]]></source>
<year>2012</year>
<conf-name><![CDATA[ XXXICongreso Mundial de Medicina Interna]]></conf-name>
<conf-loc>Santiago de Chile </conf-loc>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pizzarossa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mérola]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Borrás]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chalart]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Robaina]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalencia de la indicación y cumplimiento de la tromboprofilaxis en el Hospital de Clínicas]]></source>
<year></year>
<conf-name><![CDATA[ IVCongreso Internacional de Clínica y Medicina Interna 201442Congreso Nacional de Medicina Interna]]></conf-name>
<conf-date>2014</conf-date>
<conf-loc>Montevideo </conf-loc>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grille]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ranero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mérola]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pizzarossa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilizacion de profilaxis farmacologica para tromboembolia venosa en el paciente medico en el hospital de Clinicas, Montevideo, Uruguay]]></article-title>
<collab>Remedi A et al</collab>
<source><![CDATA[Rev urug med interna]]></source>
<year>2016</year>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>S8</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hiriart]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mendez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cuadro]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cáceres]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Silvariño]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiencia del comité de tromboprofilaxis del Sanatorio Americano]]></article-title>
<source><![CDATA[Arch Med Interna (Montevideo)]]></source>
<year>2012</year>
<volume>34</volume>
<numero>Suppl 3</numero>
<issue>Suppl 3</issue>
<page-range>S11</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cáceres]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Silvariño]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Prescription of thromboprophylaxis overt the time and successive strategies to improve it]]></source>
<year></year>
<conf-name><![CDATA[ VTE Safety Zone Latin America]]></conf-name>
<conf-date>2017</conf-date>
<conf-loc>Río de Janeiro </conf-loc>
</nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alpuin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carrizo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Asadurian]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Barneix]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Criscuolo]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[De Lisa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Logros obtenidos en prevención de la ETEV en el Hospital Maciel de Montevideo]]></source>
<year></year>
<conf-name><![CDATA[ 1erCongreso Internacional Ibero-Panamericano de Medicina InternaXXIICongreso Nacional de Medicina 2014 Argentina (CABA)]]></conf-name>
<conf-date>2014</conf-date>
<conf-loc>Buenos Aires </conf-loc>
<page-range>31-9</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Noventa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rossetto]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Brandolin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Perlati]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism The Padua Prediction Score]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2010</year>
<volume>8</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2450-7</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bahl]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Henke]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
<name>
<surname><![CDATA[Wakefield]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell a]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Caprini a]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A validation study of a retrospective venous thromboembolism risk scoring method]]></article-title>
<source><![CDATA[Ann Surg]]></source>
<year>2010</year>
<volume>251</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>344-50</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caprini]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombosis risk assessment as a guide to quality patient care]]></article-title>
<source><![CDATA[Disease-a-Month]]></source>
<year>2005</year>
<volume>51</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>70-8</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lecumberri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Panizo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez-Guiu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Varea]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[García-Quetglas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Economic impact of an electronic alert system to prevent venous thromboembolism in hospitalised patients]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2011</year>
<volume>9</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1108-15</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
